Showing results (191-200 of 444) with videos related to

Sort By:
Pageof 45
BMC Pulmonary Medicine|January 10, 2020
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosisLuca Richeldi, Martin Kolb, Stéphane Jouneau, et al.
Respirology (Carlton, Vic.)|January 7, 2012
Depression is a common and chronic comorbidity in patients with interstitial lung diseaseChristopher J Ryerson, Patricia A Arean, Jane Berkeley, et al.
The European Respiratory Journal|November 2, 2013
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposureKerri A Johannson, Eric Vittinghoff, Kiyoung Lee, et al.
Chest|June 11, 2004
Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosisHarold R Collard, Jay H Ryu, William W Douglas, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsJoyce S Lee, Harold R Collard, Kevin J Anstrom, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Annals of Internal Medicine|May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trialGanesh Raghu, Juergen Behr, Kevin K Brown, et al.
Multidisciplinary Respiratory Medicine|March 15, 2019
Agreement between chest ultrasonography and chest X-ray in patients who have undergone thoracic surgery: preliminary resultsAndrea Smargiassi, Riccardo Inchingolo, Marco Chiappetta, et al.
The European Respiratory Journal|January 26, 2023
Idiopathic pulmonary fibrosis: state of the art for 2023Anna J Podolanczuk, Carey C Thomson, Martine Remy-Jardin, et al.
Pageof 45